Evidence map›Paper›PMID 38535541›Full record

ArticlePathogens (Basel, Switzerland)2024

Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report.

Mathy Matungala-Pafubel, Junior Bulabula-Penge, Meris Matondo-Kuamfumu, Samy Esala, François Edidi-Atani, Elisabeth Pukuta-Simbu, Paul Tshiminyi-Munkamba, Yannick Tutu Tshia N'kasar, Trésor Katanga, Etienne Ndomba-Mukanya and 10 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mathy Matungala-PafubelDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Junior Bulabula-PengeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Meris Matondo-KuamfumuDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Samy EsalaDivision Provinciale de la Santé de Kinshasa, Kinshasa 01204, Democratic Republic of the Congo.
François Edidi-AtaniDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Elisabeth Pukuta-SimbuDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Paul Tshiminyi-MunkambaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Yannick Tutu Tshia N'kasarDirection de Surveillance Epidémiologique de Kinshasa, Ministère de Santé, Hygiène et Prévention, Kinshasa 01204, Democratic Republic of the Congo.
Trésor KatangaDivision Provinciale de la Santé de Kinshasa, Kinshasa 01204, Democratic Republic of the Congo.
Etienne Ndomba-MukanyaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.ORCID 0000-0001-8887-7963
Delphine Mbonga-MandeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Lionel Baketana-KinzonziDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Eddy Kinganda-LusamakiDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.ORCID 0000-0001-9795-0165
Daniel Mukadi-BamulekaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.ORCID 0000-0002-6836-8704
Fabrice Mambu-MbikaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Placide Mbala-KingebeniDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Edith Nkwembe-NgabanaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Antoine Nkuba-NdayeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.ORCID 0000-0003-2850-7498
Daniel Okitundu-LuwaCentre Neuro-Psycho-Pathologie, Kinshasa H8V3+CJ3, Democratic Republic of the Congo.
Steve Ahuka-MundekeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polio-associated paralysis is one of the diseases under national surveillance in the Democratic Republic of the Congo (DRC). Although it has become relatively rare due to control measures, non-polio paralysis cases are still reported and constitute a real problem, especially for etiological diagnosis, which is necessary for better management and response. From September 2022 to April 2023, we investigated acute flaccid paralysis (AFP) cases in Kinshasa following an alert from the Provincial Division of Health. All suspected cases and their close contacts were investigated and sampled. Among the 57 sampled patients, 21 (36.8%) were suspects, and 36 (63.2%) were contacts. We performed several etiological tests available in the laboratory, targeting viruses, including Poliovirus, Influenza virus, SARS-CoV-2, Enterovirus, and arboviruses. No virus material was detected, but the serological test (ELISA) detected antibodies against Chikungunya Virus, i.e., 47.4% (27/57) for IgM and 22.8% (13/57) for IgG. Among suspected cases, we detected 33.3% (7/21) with anti-Chikungunya IgM and 14.3% (3/21) of anti-Chikungunya IgG. These results highlight the importance of enhancing the epidemiological surveillance of Chikungunya.

Indexed as

Chikungunya FeverChikungunya virusParalysisAdolescentAdultAntibodies, ViralChildChild, PreschoolDemocratic Republic of the CongoFemaleHumansImmunoglobulin MInfantLower ExtremityMaleMiddle AgedAntibodies, ViralImmunoglobulin MchikungunyaKinshasaparalysis

Identifiers

PMID38535541
PMCPMC10974750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.